What Are the Barriers to Human Papillomavirus Vaccination for Male in South Korea?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The human papillomavirus (HPV) virus causes genital warts, a sexually transmitted disease, as well as cervical and vulvar cancer in females and penile cancer in males. In addition, it this virus causes various diseases, including head and neck cancer and anal cancer. Vaccines can prevent malignant tumors caused by the HPV virus, and various projects are being conducted to eradicate HPV worldwide. The national inoculation program is a representative project among them. In Korea, only females are vaccinated; males are not included in the national mandatory vaccination list. Various reasons preventing HPV vaccination for males include cost-effectiveness, fear and misperception of side effects after vaccination, problems with the effectiveness of vaccination, and lack of social awareness about the need for vaccination, including parents, and the lack of research on male HPV disease. As female’s right to health is emphasized, HPV disease, which has become more important in treatment, will never be cured if it is managed only for females. Because the disease is transmitted sexually, managing and controlling HPV in males is also essential. In that sense, males must also be included as nationally required vaccination targets.
Abstract
The human papillomavirus (HPV) virus causes genital warts, a sexually transmitted disease, as well as cervical and vulvar cancer in females and penile cancer in males. In addition, it this virus causes various diseases, including head and neck cancer and anal cancer. Vaccines can prevent malignant tumors caused by the HPV virus, and various projects are being conducted to eradicate HPV worldwide. The national inoculation program is a representative project among them. In Korea, only females are vaccinated; males are not included in the national mandatory vaccination list. Various reasons preventing HPV vaccination for males include cost-effectiveness, fear and misperception of side effects after vaccination, problems with the effectiveness of vaccination, and lack of social awareness about the need for vaccination, including parents, and the lack of research on male HPV disease. As female’s right to health is emphasized, HPV disease, which has become more important in treatment, will never be cured if it is managed only for females. Because the disease is transmitted sexually, managing and controlling HPV in males is also essential. In that sense, males must also be included as nationally required vaccination targets.
참고문헌 (32)
- Pahud BA, "The expanded impact of human papillomavirus vaccine", Infect Dis Clin North Am, 29, pp.715~724 (2015)
- Burd EM, "Human papillomavirus and cervical cancer", Clin Microbiol Rev, 16, pp.1~17 (2003)
- Giuliano AR, "Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men", J Infect Dis, 198, pp.827~835 (2008)
- Drake VE, "Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer", Cancer, 127, pp.1029~1038 (2021)
- Park YJ, "Annual prevalence and economic burden of genital warts in Korea : Health Insurance Review and Assessment(HIRA)service data from 2007 to 2015", Epidemiol Infect, 146, pp.177~186 (2018)
- 장인순, "청소년 성관계, 성교육 경험 및 피임실천의 추이: 2006년에서 2019년까지 청소년 건강행태 온라인 자료", 한국학교보건학회지, 33(2), pp.79~88 (2020), 한국학교보건학회[DOI]
- Bresse X, "Universal vaccination with the quadrivalent HPV vaccine in Austria : impact on virus circulation, public health and cost-effectiveness analysis", Expert Rev Pharmacoecon Outcomes Res, 14, pp.269~281 (2014)
- Chesson HW, "Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States : estimates from a simplified transmission model", Vaccine, 38, pp.8032~8039 (2020)
- Elbasha EH, "Impact of vaccinating boys and men against HPV in the United States", Vaccine, 28, pp.6858~6867 (2010)
- Haeussler K, "Cost-effectiveness analysis of universal human papillomavirus vaccination using a dynamic Bayesian methodology : the BEST II study", Value Health, 18, pp.956~968 (2015)
- Kim JJ, "The value of including boys in an HPV vaccination programme : a cost-effectiveness analysis in a low-resource setting", Br J Cancer, 97, pp.1322~1328 (2007)
- Olsen J, "Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark", Int J Technol Assess Health Care, 26, pp.183~191 (2010)
- Sharma M, "The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting", BJOG, 123, pp.917~926 (2016)
- Elbasha EH, "Age-based programs for vaccination against HPV", Value Health, 12, pp.697~707 (2009)
- Insinga RP, "Cost-effectiveness of quadrivalent human papillomavirus(HPV)vaccination in Mexico : a transmission dynamic model-based evaluation", Vaccine, 26, pp.128~139 (2007)
- Taira AV, "Evaluating human papillomavirus vaccination programs", Emerg Infect Dis, 10, pp.1915~1923 (2004)
- Zechmeister I, "Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria", Vaccine, 27, pp.5133~5141 (2009)
- Ng SS, "Systematic review of cost-effectiveness studies of human papillomavirus(HPV)vaccination : 9-valent vaccine, gender-neutral and multiple age cohort vaccination", Vaccine, 36, pp.2529~2544 (2018)
- Anic GM, "Genital HPV infection and related lesions in men", Prev Med, 53(Suppl 1), pp.S36~S41 (2011)
- Meites E, "Human papillomavirus vaccination for adults : updated recommendations of the Advisory Committee on Immunization Practices", MMWR Morb Mortal Wkly Rep, 68, pp.698~702 (2019)
- Ikeda S, "HPV vaccination in Japan : what is happening in Japan", Expert Rev Vaccines, 18, pp.323~325 (2019)
- Simms KT, "Impact of HPV vaccine hesitancy on cervical cancer in Japan : a modelling study", Lancet Public Health, 5, pp.e223~34 (2020)
- Choi Jihye, "Human Papillomavirus (HPV) Vaccination Intent among Mothers of Adolescent Sons: A National Survey on HPV Knowledge, Attitudes and Beliefs in South Korea", The World Journal of Men's Health, 41(2), pp.413~421 (2023), 대한남성과학회[DOI]
- 권택민, "Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea", Journal of Korean Medical Science, 31(3), pp.371~375 (2016), 대한의학회
- 박성진, "Prevalence and Determinants of High-Risk Human Papillomavirus Infection in Male Genital Warts", Investigative and Clinical Urology, 55(3), pp.207~212 (2014), 대한비뇨의학회
- 류경호, "Type Distribution of Human Papillomavirus in Genital Warts of Korean Men", Urogenital Tract Infection, 12(2), pp.89~94 (2017), 대한요로생식기감염학회
- Alemany L, "Role of human papillomavirus in penile carcinomas worldwide", Eur Urol, 69, pp.953~961 (2016)
- Mikamo H, "Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men : a randomized, Phase 3, placebo-controlled study", Vaccine, 37, pp.1651~1658 (2019)
- Giuliano AR, "Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males", N Engl J Med, 364, pp.401~411 (2011)
- Harder T, "Efficacy, effectiveness and safety of vaccination against human papillomavirus in males : a systematic review", BMC Med, 16, pp.110~ (2018)
- Garolla A, "Human papillomavirus prophylactic vaccination improves reproductive outcome in infertile patients with HPV semen infection : a retrospective study", Sci Rep, 8, pp.912~ (2018)
- Ciavattini A, "The impact of 9-valent HPV vaccination on couple infertility prevention: a comprehensive review", Front Med(Lausanne), 8, pp.700792~ (2021)